New York, NY -- (SBWIRE) -- 12/12/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Tesco PLC (ADR) (OTCMKTS:TSCDY), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE), AbbVie Inc (NYSE:ABBV)
Tesco PLC (ADR) (OTCMKTS:TSCDY) showed a volume of 468,971.00 shares by the end of last trade whereas the average volume of the stock remained 626,280.00 shares. The stock opened the session at $16.27 but then moved to $16.09. At that price, the stock showed a negative performance of -1.47%. Tesco PLC is an international retailer. The activity of the Company is retailing and associated activities in the United Kingdom, the People’s Republic of China, the Czech Republic, Hungary, the Republic of Ireland, India, Malaysia, Poland, Slovakia, South Korea, Thailand, Turkey and the United States. The Company also provides retail banking and insurance services through its subsidiary, Tesco Bank.
Will TSCDY Get Buyers Even After The Recent Rally? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) opened the session at $1.77 and closed the session at $1.70. The stock showed a negative performance of -3.95% in previous trading session. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels,
Has AMRN Found The Bottom And Ready To Gain Momentum? Find Out Here
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) opened the session at $4.51 and closed the session at $4.32. The stock showed a negative performance of -3.57% in previous trading session. The beta of the stock remained 2.61. Yingli Green Energy Holding Company Limited is a vertically integrated photovoltaic (PV), product manufacturer worldwide. The Company designs, manufactures and sells PV modules, and design, assemble, sell and install PV systems. Its products and services substantially cover the entire PV industry value chain,
Why Should Investors Buy YGE After the Recent Fall? Just Go Here and Find Out
AbbVie Inc (NYSE:ABBV) the stock advanced 1.02% and finished the session at $52.67. Traded with volume of 10.77 million shares in the prior session and the average volume of the stock remained 5.15 million shares. The beta of the stock remained 0.001. AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products,
Will ABBV Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)